Screening of the prostate cancer. «Instantaneous» of a daily practice among 300 general practitioners of the canton of Vaud;Dépistage du cancer de la prostate. «Instantané» d'une pratique quotidienne parmi 300 médecins généralistes du canton de Vaud

Revue Medicale Suisse

Volumn 1, Issue 44, 2005, Pages 2840-2842

  Praz, Valentin ^a   Jichlinski, Patrice ^a   Aymon, Danièla ^a   Leisinger, Hans Jürg ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MEDICAL SOCIETY; PROSTATE CANCER; SWITZERLAND; ADULT; AGED; CLINICAL PRACTICE; EPIDEMIOLOGY; MALE; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PHYSICAL EXAMINATION; PROSTATE TUMOR; RECTUM; STATISTICS;

ADULT; AGED; HEALTH CARE SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; SWITZERLAND;

EID: 33644668975     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zouhair A, Mirimanoff RO. Place de la radiothérapie dans le traitement du cancer de la prostate. Med Hyg 2003;61:2386-8.
2. Deperthes D, Gygi CM, Jichlinski P, et al. L'antigène spécifique de la prostate (PSA): un marqueur tumoral en fin de règne? Med Hyg 2003;61:2377-81.
3. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;45:907-23.
4. Catalona WJ, Loeb S. The PSA Era not Over for Prostate Cancer. Eur Urol. 2005;48:541-5.
5. Jonler M, Eddy B, Poulsen J. Prostate-specific antigen testing in general practice: A survey among 325 general practitioners in Denmark. Scand J Urol Nephrol. 2005;39:214-8.
6. Durham J, Low M, McLeod D. Screening for prostate cancer: A survey of New Zealand general practitioners. N Z Med J 2003;116;U476
7. Morris J, McNoe B. Screening for prostate cancer: What do general practitioners think? N Z Med J 1997;110:178-82.
8. Aus C, Abbou CC, Bolla M, et al. EAU Guidelines on Prostate Cancer. Eur Urol. 2005;48:546-51.
9. PSA: Best practice policy guidelines from the American Urological Association.
10. Schmid HP, Kiesen W, Prikler L. Update on screening for prostate cancer with prostate-specific antigen. Crit Rev Oncol Hematol 2004;50:71-8.
11. Vincenbeau S, Abi Moussa M, Manunta A, et al. PSA: le difficile positionnement du médecin généraliste entre patients et urologues. Prog Urol 2003;13:252-5.
12. Mercer SL, Goel V, Levy IG. Prostate cancer screening in the midst of controversy : Canadian men's knowledge, beliefs utilization and future intentions. Can J Public Health. 1997;88:327-32.
13. Zhu H, Roehl KA,Antenor JAV, et al. Biopsy of men PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: A preliminary analysis. Urology 2005;66:547-51.
14. Zellweger T, Gasser T. Urologie: PSA - malédiction ou bénédiction? Forum Med Suisse 2003;51/52:1284-6.